Skip to content

Microglial activation on autism spectrum disorder: positron emission tomography study

In vivo imaging of microglial activation on autism spectrum disorder: positron emission tomography study - In vivo imaging of microglial activation on autism spectrum disorder: positron emission tomography study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052816
Enrollment
100
Registered
2023-11-20
Start date
2023-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

None listed

Sponsors

Hamamatsu University School of Medicine
Lead Sponsor
Hamamatsu Medical Photonics Foundation, National Center of Neurology and Psychiatry
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals with ASD or typically developing subjects participated in the [11C]PK11195 PET study held by Department of Psychiatry in Hamamatsu University School of Medicine from 1st March 1997 to 31th March 2023.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The availability of PET tracer

Countries

Japan

Contacts

Public ContactMasamichi Yokokura

Hamamatsu University School of Medicine Psychiatry

ykkr@hama-med.ac.jp0534352295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026